Compare ALKS & AXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ALKS | AXS |
|---|---|---|
| Founded | 1987 | 2001 |
| Country | Ireland | Bermuda |
| Employees | 2050 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.4B | 7.1B |
| IPO Year | 2012 | 2003 |
| Metric | ALKS | AXS |
|---|---|---|
| Price | $45.24 | $101.10 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 20 | 12 |
| Target Price | $56.21 | ★ $119.55 |
| AVG Volume (30 Days) | ★ 1.9M | 644.4K |
| Earning Date | 11-03-2026 | 10-28-2026 |
| Dividend Yield | N/A | ★ 1.72% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 3.29 |
| Revenue | $1,475,899,000.00 | ★ $6,563,678,000.00 |
| Revenue This Year | $23.57 | N/A |
| Revenue Next Year | $6.58 | $6.85 |
| P/E Ratio | ★ N/A | $31.03 |
| Revenue Growth | N/A | ★ 10.17 |
| 52 Week Low | $27.00 | $89.48 |
| 52 Week High | $55.67 | $119.99 |
| Indicator | ALKS | AXS |
|---|---|---|
| Relative Strength Index (RSI) | 59.90 | 58.87 |
| Support Level | $39.41 | $97.45 |
| Resistance Level | $45.20 | $102.76 |
| Average True Range (ATR) | 1.39 | 1.80 |
| MACD | 0.62 | 0.54 |
| Stochastic Oscillator | 96.63 | 60.84 |
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.
Axis Capital Holdings Ltd is a specialty underwriter and provider of insurance and reinsurance solutions with operations in Bermuda, the United States (U.S.), Europe, Singapore, and Canada. The company manages its portfolio holistically, aiming to construct an optimum consolidated portfolio of funded and unfunded risks. The company's segment consists of Insurance and Reinsurance. The company generates the majority of its revenue from the Insurance segment. Geographically, the company generates the majority of its revenue from the United States, and also has its presence in Ireland, Lloyd's of London, and Bermuda.